Suppr超能文献

基质金属蛋白酶组织抑制因子-1以及微血管侵犯和高核分级是局限性肾细胞癌肿瘤直径增大的重要决定因素。

TIMP-1 as well as Microvessel Invasion and High Nuclear Grade Is a Significant Determinant Factor for Extension of Tumor Diameter in Localized RCC.

作者信息

Kawata Nozomu, Yamaguchi Kenya, Igarashi Tomohiro, Takahashi Satoru

机构信息

Department of Urology, Nihon University School of Medicine, 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan.

出版信息

J Oncol. 2016;2016:5035127. doi: 10.1155/2016/5035127. Epub 2016 Feb 25.

Abstract

Objectives. To clarify what kind of pathological factor is necessary for the extension of tumor diameter in localized RCC, we studied localized RCC patients. Methods. We retrospectively reviewed medical records of 237 RCC patients in our institute who underwent nephrectomy. We performed immune histological analysis of MMP-2, MMP-9, TIMP-1, TIMP-2, and MT-MMP-1 for all samples. Results. Among the clinicopathological factors, multivariate analysis revealed nuclear grade; TIMP-2 and MT-MMP-1 were independent prognostic factors of localized RCC (risk ratio 1.50, p = 0.037, risk ratio 1.12, p = 0.008, and risk ratio 1.84, p = 0.045, resp.). By the multiple logistic regression analysis among pT1a versus pT1b, TIMP-1 was an independent factor (risk ratio 3.30, p = 0.010) whereas all pT1 versus pT2a and all pT1 + pT2a versus pT2b high nuclear grade (risk ratio 5.15, p = 0.0015) and Micro vessel invasion (MVI, risk ratio 3.08, p = 0.002) were independent factors. For all pT1 + pT2a versus pT2b, nuclear grade (risk ratio 3.39, p = 0.020) and MVI (risk ratio 2.91, p = 0.018) were independent factors. Conclusion. Higher expression of TIMP-1 is necessary for advancement tumor diameter from pT1a to pT1b, and a process of tumor diameter extension beyond pT1 and pT2a category needs presence of MVI and high nuclear grade.

摘要

目的。为明确在局限性肾细胞癌(RCC)中肿瘤直径增大所需的病理因素类型,我们对局限性RCC患者进行了研究。方法。我们回顾性分析了我院237例行肾切除术的RCC患者的病历。对所有样本进行了基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、金属蛋白酶组织抑制因子-1(TIMP-1)、金属蛋白酶组织抑制因子-2(TIMP-2)和膜型基质金属蛋白酶-1(MT-MMP-1)的免疫组织化学分析。结果。在临床病理因素中,多因素分析显示核分级;TIMP-2和MT-MMP-1是局限性RCC的独立预后因素(风险比分别为1.50,p = 0.037;风险比为1.12,p = 0.008;风险比为1.84,p = 0.045)。在pT1a与pT1b的多因素逻辑回归分析中,TIMP-1是独立因素(风险比为3.30,p = 0.010),而在所有pT1与pT2a以及所有pT1 + pT2a与pT2b中,高核分级(风险比为5.15,p = 0.0015)和微血管侵犯(MVI,风险比为3.08,p = 0.002)是独立因素。对于所有pT1 + pT2a与pT2b,核分级(风险比为3.39,p = 0.020)和MVI(风险比为2.91,p = 0.018)是独立因素。结论。TIMP-1的高表达是肿瘤直径从pT1a进展到pT1b所必需的,而肿瘤直径扩展超过pT1和pT2a类别的过程需要存在MVI和高核分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4785260/3c7872819c02/JO2016-5035127.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验